Association of coronary plaque rupture and atherosclerotic inflammation

Journal of Pathology

Volumn 181, Issue 1, 1997, Pages 93-99

  Boyle, J J ^a,b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

atherosclerosis; coronary artery; macrophage; myocardial infarction; plaque rupture; T lymphocyte

Indexed keywords

CD3 ANTIGEN; CD30 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOPSY; CORONARY ARTERY THROMBOSIS; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ARTERITIS; CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; HUMANS; IMMUNOENZYME TECHNIQUES; MACROPHAGES; MYOCARDIAL INFARCTION; T-LYMPHOCYTE SUBSETS;

EID: 0031046601     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199701)181:1<93::AID-PATH696>3.0.CO;2-H     Document Type: Article

References (32)

1. Hansson GK, Jonasson L, Seifert PS, et al. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989; 9: 567-578.
2. Parums DV. Inflammatory mediators in atherosclerosis. Biochem Soc Trans 1990; 18: 1009-1072.
3. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169-175.
4. Van Der Wal AC, Das PK, van der Berg DB, van der Loos CM, Becker AE. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989; 61: 166-170.
5. Hertualla S, Rosenfeld ME, Parthasarthy S, et al. Gene expression in macrophage rich human atherosclerotic lesions: 15-lipoxygenase and acetyl low density lipoprotein messenger RNA colocalise with oxidation specific lipid-protein adducts. J Clin Invest 1991; 87: 1146-1152.
6. Stemme S, Faber B, Holm J, Wiklund D, Witzum JL, Hansson GK. T-lymphocytes from human atherosclerotic plaques recognise oxidised low density lipoprotein. Proc Natl Acad Sci USA 1995; 92: 3893-3897.
7. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina. Br Heart J 1985; 53: 363-373.
8. Davies MJ, Thomas AC. Thrombosis and acute coronary lesions in sudden cardiac death. N Engl J Med 1984; 310: 1137-1140.
9. Falk E, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-665.
10. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850.
11. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation 1994; 89: 503-505.
12. Van Der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterised by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
13. DiSciascio G, Cowley MJ, Goudreau E, Vetrover GW, Johnson DE. Histopathologic correlates of unstable ischemic syndromes in patients undergoing directional coronary atherectomy: in vivo evidence of thrombosis, ulceration, and inflammation. Am Heart J 1994; 128: 419-426.
14. Arbustini E, De Servi S, Bramucci E, et al. Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina and restenosis after either atherectomy or angioplasty. Am J Cardiol 1995; 75: 675-682.
15. Moreno PR, Fak E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implication for plaque rupture. Circulation 1994; 90: 1669-1678.
16. Constantinides P. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995; 92: 1083-1088.
17. Kaartinen M, Pentilla A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994; 90: 1669-1678.
18. Henney AM, Wakely PR, Davies MJ, et al. Localisation of stromelysin gene product in atherosclerotic plaques by in situ hybridisation. Proc Natl Acad Sci USA 1991; 88: 8154-8158.
19. Gallis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading enzymes in vulnerable regions of human atherosclerotic plaques. J Clin Invent 1992; 94: 2493-2503.
20. Jean Claude J, Newman KM. Li H, et al. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery 1994; 116: 472-478.
21. Pesoven E, Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 1981; 101: 512-513.
22. Warnes CA, Roberts WC. Comparison at necropsy by age group of amount and distribution of narrowing by atherosclerotic plaque in 2995 five mm long sections of 240 major coronary arteries in 60 men aged 31 to 70 years with sudden coronary death. N Engl J Med 1992; 108: 431-435.
23. Roberts WC. Qualitative and quantitative comparison of amounts of narrowing by atherosclerotic plaques in the major epicardial coronary arteries at necropsy in sudden coronary death, transmural acute myocardial infarction, transmural healed myocardial infarction and instable angina pectoris. Am J Cardiol 1989; 64: 324-328.
24. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid. macrophage, and smooth muscle content. Br Heart J 1993; 69: 377-381.
25. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995; 333: 1301-1307.
26. Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. J Am Med Assoc 1990; 263: 2204-2207.
27. Hendrix MG, Daemen M, Bruggeman CA. Cytomegalovirus expression within the human vascular tree. Am J Pathol 1991; 138: 563-567.
28. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994; 42: 170-174.
29. Billingham ME. Histopathology of graft coronary artery disease. J Heart Lung Transplant 1992; 11: 538-544.
30. Galtier-Dereure F, Capony F, Maudelonde T, Rochefort H. Estradiol stimulates cell growth and secretion of procathepsin D and a 120 kilodalton protein in the ovarian carcinoma cell line BG-1. J Clin Endocrinol Metab 1992; 75: 1497-1502.
31. Brizzo P, Badett J, Capony F, Pieri I, Montcourier P, Barritault D. MCF-7 mammary cancer cells respond to bFGF and internalise it following its release for extracellular matrix: a permissive role for cathepsin D. Exp Cell Res 1991; 194: 252-259.
32. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77: 863-868.